These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 25831830)
1. [Adverse event and countermeasure with regard to FOLFIRINOX for pancreatic cancer]. Koga F; Ueno H; Morizane C; Kondo S; Sakamoto Y; Okusaka T Nihon Rinsho; 2015 Feb; 73 Suppl 2():597-603. PubMed ID: 25831830 [No Abstract] [Full Text] [Related]
2. [Systemic chemotherapy and chemoradiotherapy for advanced pancreatic cancer]. Ueno H; Okusaka T Gan To Kagaku Ryoho; 2012 Mar; 39(3):357-63. PubMed ID: 22421761 [TBL] [Abstract][Full Text] [Related]
3. Treatment options for advanced pancreatic cancer: a review. Warsame R; Grothey A Expert Rev Anticancer Ther; 2012 Oct; 12(10):1327-36. PubMed ID: 23176620 [TBL] [Abstract][Full Text] [Related]
4. Weekly mitoxantrone in the treatment of advanced pancreatic carcinoma: a Southeastern Cancer Study Group Trial. DeSimone PA; Gams R; Bartolucci A Cancer Treat Rep; 1986 Jul; 70(7):929-30. PubMed ID: 3521850 [No Abstract] [Full Text] [Related]
6. Antibody-drug conjugate may inhibit pancreatic cancer. Cancer Discov; 2013 Dec; 3(12):OF1. PubMed ID: 24327698 [No Abstract] [Full Text] [Related]
7. [Activity of Taxanes for advanced and recurrent pancreatic cancer]. Boku N; Fukutomi A Nihon Rinsho; 2006 Jan; 64 Suppl 1():207-10. PubMed ID: 16457251 [No Abstract] [Full Text] [Related]
8. Current status of chemotherapy in metastatic pancreatic cancer. Wils JA Anticancer Res; 1989; 9(4):1027-31. PubMed ID: 2683988 [TBL] [Abstract][Full Text] [Related]
9. Cetuximab: still an option in the treatment of pancreatic cancer? Faloppi L; Andrikou K; Cascinu S Expert Opin Biol Ther; 2013 May; 13(5):791-801. PubMed ID: 23560505 [TBL] [Abstract][Full Text] [Related]
10. Patients with pancreatic cancer participating in clinical trials: are targets being met, and if not, why? Board RE; Thorley D; Hawkins RE; Valle JW Pancreas; 2007 Mar; 34(2):269-70. PubMed ID: 17312469 [No Abstract] [Full Text] [Related]
11. Trials of single-agent and combination chemotherapy for advanced cancer of the pancreas. Horton J; Gelber RD; Engstrom P; Falkson G; Moertel C; Brodovsky H; Douglass H Cancer Treat Rep; 1981; 65(1-2):65-8. PubMed ID: 6452948 [TBL] [Abstract][Full Text] [Related]
12. Role of everolimus in pancreatic neuroendocrine tumors. Goldstein R; Meyer T Expert Rev Anticancer Ther; 2011 Nov; 11(11):1653-65. PubMed ID: 21932937 [TBL] [Abstract][Full Text] [Related]
13. Chemotherapy and cancer of the gastrointestinal tract. Terz JJ; Beatty JD Surg Annu; 1979; 11():149-80. PubMed ID: 388686 [TBL] [Abstract][Full Text] [Related]
14. Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside. Yang F; Jin C; Jiang Y; Li J; Di Y; Ni Q; Fu D Cancer Treat Rev; 2011 Dec; 37(8):633-42. PubMed ID: 21330062 [TBL] [Abstract][Full Text] [Related]
15. Chemotherapy in cancer of the liver, pancreas and bile ducts. Consensus statement of a workshop at The Swedish Society for Upper Abdominal Surgery sponsored by the Swedish Cancer Society. Ihse I Eur J Surg; 1998 Jan; 164(1):3-4. PubMed ID: 9537701 [No Abstract] [Full Text] [Related]
16. CA 19-9 and pancreatic carcinoma, a revival? Ducreux M; Boige V; Malka D Onkologie; 2007 Feb; 30(1-2):12-3. PubMed ID: 17264520 [No Abstract] [Full Text] [Related]
17. Phase II evaluation of amsacrine in colorectal, gastric, and pancreatic carcinomas: a Southeastern Cancer Study Group trial. Omura GA; Bartolucci AA; Lessner HE; Hill GJ Cancer Treat Rep; 1984 Jun; 68(6):929-30. PubMed ID: 6547369 [No Abstract] [Full Text] [Related]
18. Pancreatic cancer: a plea for more trials. Van Cutsem E; Fevery J Eur J Cancer; 1995 Jun; 31A(6):867-9. PubMed ID: 7544144 [No Abstract] [Full Text] [Related]
19. Everolimus 10 mg and pancreatic neuroendocrine tumours: many adverse effects and uncertain benefit. Prescrire Int; 2012 Oct; 21(131):234. PubMed ID: 23185844 [TBL] [Abstract][Full Text] [Related]